Stockreport

JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT [Yahoo! Finance]

ResMed Inc.  (RMD) 
Last resmed inc. earnings: 4/30 04:05 pm Check Earnings Report
PDF JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT On April 15, 2026, JPMorgan initiated coverage of ResMed Inc. (NYSE:RMD) with an “Overweight” r [Read more]